Greetings from Dr. Zhizhuang Zhao, Dr. Delong Liu and the Editorial Office of SCI!
We are glad to present the 2021 Annual Report of SCI. There were 25 articles published in SCI and the total retrieval of the journal in PubMed has increased in the past 2021. More information is shown in the Annual Report.
We hereby thank you for your ongoing support in developing the journal as our editorial board members, guest editors, reviewers, authors and readers. We hope that 2022 will bring greater developments to the journal to reach new heights and wish you a happy, healthy and prosperous 2022!
Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Stem Cell Investigation (SCI) is among the list of COPE membership.
AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020. Around 60 AME journals’ peer review systems are now integrated seamlessly into the Publons platform (https://publons.com/about/home). The partnership was done to recognize our expert peer reviewers spontaneously for their review contribution.
The number of type-2 diabetes mellitus (T2DM) is continuously rising globally. Stromal vascular fraction, which contains adipose tissue stem cells, is an alternative therapy that is developed to overcome T2DM.
Various methods of cell pausing were applied to prevent proliferation of cultured cells, which either required special medium, using complicated encapsulation method, or using a special flask (Petaka G3 flask).
CD44 is expressed in stem cells and cells in the niches surrounding them, including inflammatory cells, suggesting that CD44 may play an important role in reparative processes within ischemic areas under neuroinflammatory conditions; in particular, strokes.
The achievement of optimal number of CD34+ umbilical cord stem cells is essential for successful umbilical cord stem cell transplantation. So the aim of this study was to assess the potential effect of both maternal and neonatal factors on the umbilical cord blood CD34+ cell count.
The Stem Cell Investigation welcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.
For completeness and transparency for published case reports, the Stem Cell Investigation will apply the CARE guidelines (1) as reporting standards for case reports starting from October 14, 2019. For any submission of case report after the date:
Stem Cell Investigation is an international, open access, peer-reviewed, PubMed-indexed online journal covering basic, translational, and clinical research on all aspects of stem cells, e.g. embryonic stem cells, induced pluripotent stem cells, adult tissue-specific stem/progenitor cells, cancer stem like cells, stem cell niche, stem cell technology, stem cell based drug discovery, and regenerative medicine.